New report from Fraser Institute compares drug costs in Canada and U.S., and concludes that Canada's heavy government involvement in prescription drug markets offers no real cost advantage for patients. Consumers in the U.S. and Canada spend roughly the same proportion of the per capita gross incomes on prescription drugs. And on an after-tax basis, the cost burden is higher in Canada, according...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Canada's cost advantage on prescription drugs: It's less than you think
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account